title: A survey of attitudes among drug user treatment providers toward the treatment of inhalant users.
abstract: This study assessed the attitudes of drug user treatment program directors towards the problem of inhalant "abuse." In 2000, surveys were mailed to directors asking about treatment success and prognosis for inhalant users, level of neurological damage incurred by users, availability of treatment resources, their program's policies toward admission of users, and staff training needs for inhalant use. Two open-ended questions queried their assessment of barriers to treatment and subjective feelings about the topic of inhalant use. Five hundred and fifty responses were received. Findings show that program directors perceive a great deal of neurological damage incurred through inhalant use and have a general pessimism about treatment effectiveness and recovery. The respondents also felt that there were insufficient resources for inhalant user treatment and that special staff training in the area was needed. The majority of the directors indicated that they have or would treat inhalant users. Implications for future research and policy change are discussed.
authors.affiliation: Tri-Ethnic Center for Prevention Research, Department of Psychology, Colorado State University, Fort Collins 80523, USA. beauvais@lamar.colostate.edu
authors.forename: Frederick
authors.initials: F
authors.lastname: Beauvais
authors.forename: Pamela
authors.initials: P
authors.lastname: Jumper-Thurman
authors.forename: Barbara
authors.initials: B
authors.lastname: Plested
authors.forename: Heather
authors.initials: H
authors.lastname: Helm
mesh_terms: D000280:Administration, Inhalation; D001291:Attitude of Health Personnel; D005260:Female; D019538:Health Care Surveys / Q000706:statistics & numerical data; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D016320:Substance Abuse Treatment Centers / Q000706:statistics & numerical data; D019966:Substance-Related Disorders / Q000517:prevention & control / Q000628:therapy*; D014481:United States